Skip to content

Addiction: all studies

Page 503 of 863: studies 5,021 to 5,030 of 8,627, newest first. Back to the addiction overview

Research

Magnesium in Ketamine Administration in Treatment-Resistant Depression

Pharmaceuticals May 3, 2021 Natalia Górska, Wiesław Jerzy Cubała, Jakub Słupski et al. 2 citations

Relationship between depression and magnesium levels is reported. This observational study examined whether serum magnesium concentration change over time of ketamine treatment course, also whether association between magnesium concentrations and treatment response measured with Montgomery-Åsberg Depression Rating Scale (MADRS) score occurs. Moreover, interlink between changes in Young Mania...

DOI: 10.3390/ph14050430 (opens in new tab) Ketamine Magnesium Depression economics Mania +7

Viewing personalized video clips recommended by TikTok activates default mode network and ventral tegmental area

Neuroimage May 2, 2021 Conghui Su, Hui Zhou, Liang Gong et al.

Cutting-edge recommendation algorithms have been widely used by media platforms to suggest users with personalized content. While such user-specific recommendations may satisfy users' needs to obtain intended information, some users may develop a problematic use pattern manifested by addiction-like undesired behaviors. Using a popular video sharing and recommending platform (TikTok) as an...

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and d‐methamphetamine on pro‐social behavior in drug‐naïve female nonhuman primates

The FASEB Journal May 1, 2021 Alison Wakeford, Marissa Costa, Hannah Alton et al.

Previous preclinical studies have demonstrated that 3,4‐methylenedioxymethamphetamine (MDMA) dose‐dependently increases pro‐social behavior and affiliative vocalizations in male nonhuman primates. As diagnostic criteria for several psychiatric diseases includes deficits in social functioning, examining the conditions under which MDMA selectively increases pro‐social behavior may provide...

Antibody Gene Therapy Mitigates the immunosuppressive effects of 3,4‐Methylenedioxymethamphetamine (MDMA) in the periphery of Male BALB/c Mice

The FASEB Journal May 1, 2021 Chris Bolden, Cameron Tilley, Charles E Hay et al.

3,4‐Methylenedioxymethamphetamine (MDMA) is currently one of the most popular club psychostimulant and hallucinogens. MDMA's primary site of action is in the brain where it produces a “euphoric” feeling, this euphoria comes with a multitude of acute toxicities. In the periphery, MDMA acts as an immunosuppressive agent in the periphery decreasing the robust activity of the adaptive and innate...

GluN2B‐containing NMDA Receptors on Sst‐interneurons act as Initial Cellular Trigger for Antidepressant Actions of Ketamine

The FASEB Journal May 1, 2021 Santosh Pothula, Rongjian Liu, Min Wu et al.

A single subanesthetic dose of ketamine exerts rapid antidepressant‐like effects via rapid glutamate efflux, activation of mTORC1 signaling, and enhanced synaptic transmission in the medial prefrontal cortex (mPFC); however, the initial cellular trigger for these synaptic and behavioral actions of ketamine still remains unclear. Here, we used electrophysiology, biochemistry, molecular biology...

DOI: 10.1096/fasebj.2021.35.s1.02392 (opens in new tab) Disinhibition Neurotransmission Inhibitory postsynaptic potential Excitatory postsynaptic potential +6

The human visual system differentially represents subjectively and objectively invisible stimuli.

PLoS Biology May 1, 2021 Timo Stein, Daniel Kaiser, Johannes J Fahrenfort et al.

The study of unconscious processing requires a measure of conscious awareness. Awareness measures can be either subjective (based on participant's report) or objective (based on perceptual performance). The preferred awareness measure depends on the theoretical position about consciousness and may influence conclusions about the extent of unconscious processing and about the neural correlates...

Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.

Journal of Psychiatric Research May 1, 2021 Bruno Romeo, Marianne Hermand, Amélie Pétillion et al. 74 citations

The use of psychedelic treatments has shown very promising results in some psychiatric and addictive disorders, but not all patients achieved a response. The aim of this review is to explore the clinical and biological factors which could predict the response to psychedelics in psychiatric and addictive disorders. A systematic research was performed on MEDLINE, PsycInfo, Web of science, and...

Higher-order sensorimotor circuit of the brain's global network supports human consciousness.

Neuroimage May 1, 2021 Pengmin Qin, Xuehai Wu, Changwei W Wu et al. 51 citations

Consciousness is a mental characteristic of the human mind, whose exact neural features remain unclear. We aimed to identify the critical nodes within the brain's global functional network that support consciousness. To that end, we collected a large fMRI resting state dataset with subjects in at least one of the following three consciousness states: preserved (including the healthy awake...

DOI: 10.1016/j.neuroimage.2021.117850 (opens in new tab) Full text (opens in new tab) Anesthesia Degree centrality Disorders of consciousness Higher-order sensorimotor circuit +1

Giving Up on Consciousness as the Ghost in the Machine

Frontiers in Psychology April 30, 2021 Peter W Halligan, David A Oakley

Consciousness as used here, refers to the private, subjective experience of being aware of our perceptions, thoughts, feelings, actions, memories (psychological contents) including the intimate experience of a unified self with the capacity to generate and control actions and psychological contents. This compelling, intuitive consciousness-centric account has, and continues to shape folk and...

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?

Frontiers in Neuroscience April 30, 2021 E. Carboni, A. Carta, Elena Carboni et al. 28 citations

Repurposing ketamine in the therapy of depression could well represent a breakthrough in understanding the etiology of depression. Ketamine was originally used as an anesthetic drug and later its use was extended to other therapeutic applications such as analgesia and the treatment of addiction. At the same time, the abuse of ketamine as a recreational drug has generated a concern for its...